European Medicines Agency (EMA) | What's new Follow Orphan designation: Elafibranor Treatment of primary sclerosing cholangitis, 18/07/2025 Positive https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-25-3100 ema.europa.eu
